|
|
One Park Place, Suite 450
Annapolis, MD 21401 USA
phone:410-269-2600
fax:410-269-2601
|
|
| Symbol |
PIP |
| Exchange |
AMEX |
| Founded |
2001 |
| Employees |
|
|
|
| www.pharmathene.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Countermeasures for bioterrorism. |
|
| Management |
| David P. Wright, President & Chief Executive Officer; Charles A. Reinhart III, Senior Vice President, Chief Financial Officer; Christopher C. Camut, Vice President, Government Contracting and Special Projects; Francesca Cook, Vice President, Policy & Government Affairs; Wayne Morges, Ph.D., Vice President, Regulatory Affairs & Quality |
| |
|
|
|
|
|
|
| |
|
|
|
|
| Keywords |
| countermeasures, pharmaceutical, biotechnology, prophylactic, biodefense |
|
|
|
|
|
|
| Description |
|
PharmAthene focuses on the development of effective countermeasures to a range of potential biological and chemical weapons. |
|
| Products / Services |
PharmAthene's product Protexia is developed as a pre- and post-exposure therapy for casualties on the battlefield or civilian victims of nerve agent attacks. Volartim is a fully human antibody designed to protect against inhalation anthrax, the most lethal form of illness in humans caused by the Bacillus anthracis bacterium more...
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members